On May 23, 2025, Kent Lake PR LLC, a holder of approximately 6.9% of Quanterix Corporation's common stock, issued a statement regarding the company's amended merger terms with Akoya Biosciences and Akoya's disclosure of an unsolicited all-cash offer at $1.40 per share.
Kent Lake noted that Akoya's third-party all-cash offer represented a 22% premium over Akoya's 30-day VWAP and Quanterix's implied offer price under the amended merger agreement. To match this, Quanterix would need to increase its cash consideration by an additional $20 million.
Kent Lake urged the Quanterix Board to allow Akoya to accept the superior proposal without increasing Quanterix's purchase consideration, or to consider running a strategic alternatives process for Quanterix itself. The firm stated that increasing the Akoya purchase consideration would create significant balance sheet risk and represent a breach of fiduciary duty.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.